About Pangea Bio
Pangea Bio is a company founded in 2021 by Thomas Pfeiffer, Manon Veraart, Lars Wilde, John Boghossian, Julia Wilde, and Lars Christian Wilde.. Pangea Bio has raised $11.57 million across 3 funding rounds. Pangea Bio offers products and services including PangeaAI and OT-003. Pangea Bio operates in a competitive market with competitors including Ceretype, Pangea Botanica, cfdx, WM Therapeutics and La Jolla Labs, among others.
- Founders Thomas Pfeiffer, Manon Veraart, Lars Wilde, John Boghossian, Julia Wilde, Lars Christian Wilde
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pangea Botanica Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.57 M (USD)
in 3 rounds
-
Latest Funding Round
$11.57 M (USD), Seed
Apr 21, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pangea Bio
Pangea Bio offers a comprehensive portfolio of products and services, including PangeaAI and OT-003. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for uncovering natural molecules in drug discovery processes
Nature-inspired compound targeting neurological disease models
Unlock access to complete
Funding Insights of Pangea Bio
Pangea Bio has successfully raised a total of $11.57M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $11.57 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $11.6M
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Seed - Pangea Bio | Valuation |
investors |
|
| Apr, 2022 | Amount | Seed - Pangea Bio | Valuation |
investors |
|
| Apr, 2021 | Amount | Seed - Pangea Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Pangea Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pangea Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pangea Bio Comparisons
Competitors of Pangea Bio
Pangea Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceretype, Pangea Botanica, cfdx, WM Therapeutics and La Jolla Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based brain biomarker technology to improve drug discovery and patient care
|
|
| domain | founded_year | HQ Location |
AI-driven drug discovery for CNS disorders using natural compounds.
|
|
| domain | founded_year | HQ Location |
Neuroscience platform for neurogeneration research and diagnostics is provided.
|
|
| domain | founded_year | HQ Location |
Small-molecule cancer therapeutics are developed to inhibit Warburg metabolism.
|
|
| domain | founded_year | HQ Location |
RNA therapeutics for rare diseases are discovered using AI platforms.
|
|
| domain | founded_year | HQ Location |
Therapeutics for brain health are developed via a programmable platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Pangea Bio
When was Pangea Bio founded?
Pangea Bio was founded in 2021.
Who is the current CEO of Pangea Bio?
Lars Wilde is the current CEO of Pangea Bio. They have also founded this company.
Is Pangea Bio a funded company?
Pangea Bio is a funded company, having raised a total of $11.57M across 3 funding rounds to date.
What does Pangea Bio do?
Pangea Bio was founded in 2021 in the biotechnology sector, where nature-inspired therapeutics for neurological and neuropsychiatric disorders are developed. Artificial intelligence is utilized to identify molecules from natural sources, supporting a research program that targets unmet needs in central nervous system diseases. Traditional knowledge is preserved through operations that emphasize reciprocity with knowledge holders.
Who are the top competitors of Pangea Bio?
Pangea Bio's top competitors include Ceretype, cfdx and La Jolla Labs.
What products or services does Pangea Bio offer?
Pangea Bio offers PangeaAI and OT-003.